We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. The Role of Immunotherapy in Renal Cell Carcinoma

    Immunotherapy has long played an integral role in the treatment of advanced renal cell carcinoma, beginning with interleukin-2 and interferon-α and...
    Sai Krishnaraya Doppalapudi, Alain Kaldany, ... Eric A. Singer in Handbook of Cancer and Immunology
    Living reference work entry 2023
  2. Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesions

    Background

    Despite therapeutic advances, once a cancer has metastasized to the bone, it represents a highly morbid and lethal disease. One third of...

    Shenglin Mei, Adele M. Alchahin, ... Ninib Baryawno in Genome Medicine
    Article Open access 29 January 2024
  3. Evolution of cell therapy for renal cell carcinoma

    Treatment for renal cell carcinoma (RCC) has improved dramatically over the last decade, shifting from high-dose cytokine therapy in combination with...

    Yufei Wang, Eloah Rabello Suarez, ... Wayne A. Marasco in Molecular Cancer
    Article Open access 09 January 2024
  4. Renal Cell Carcinomas

    This chapter highlights the molecular mechanisms in some of the many different tumor types that originate in the adult kidney. Renal cell carcinomas...
    Wolfgang A. Schulz in Molecular Biology of Human Cancers
    Chapter 2023
  5. Prognostic Significance of Tumor-Associated Inflammation in Renal Cell Carcinoma

    This study analyzed tumor-associated inflammation by assessing the expression of cyclophilin A (CypA) and TNF in samples of kidney tumors of various...

    O. V. Kovaleva, P. A. Podlesnaya, ... A. N. Gratchev in Bulletin of Experimental Biology and Medicine
    Article 01 January 2024
  6. Genomic and transcriptomic features between primary and paired metastatic fumarate hydratase–deficient renal cell carcinoma

    Background

    Fumarate hydratase–deficient renal cell carcinoma (FH-RCC) is a rare highly aggressive subtype of kidney cancer for which the distinct...

    Jiayu Liang, Guangxi Sun, ... **ngming Zhang in Genome Medicine
    Article Open access 02 May 2023
  7. Deep learning-based pathological prediction of lymph node metastasis for patient with renal cell carcinoma from primary whole slide images

    Background

    Metastasis renal cell carcinoma (RCC) patients have extremely high mortality rate. A predictive model for RCC micrometastasis based on...

    Feng Gao, Liren Jiang, ... **ang Wang in Journal of Translational Medicine
    Article Open access 14 June 2024
  8. Metabolic heterogeneity in clear cell renal cell carcinoma revealed by single-cell RNA sequencing and spatial transcriptomics

    Background

    Clear cell renal cell carcinoma is a prototypical tumor characterized by metabolic reprogramming, which extends beyond tumor cells to...

    Guanwen Yang, Jiangting Cheng, ... Hang Wang in Journal of Translational Medicine
    Article Open access 27 February 2024
  9. Clinical and genomic features in patients with second primary glioblastoma following first primary renal cell carcinoma

    Purpose

    To explore the potential pathogenesis and clinical features of second primary glioblastoma (spGBM) following first primary renal cell...

    Guang-Tao Zhang, Qi Liu, ... Hong-Qing Cai in BMC Cancer
    Article Open access 30 January 2023
  10. The microbiota and renal cell carcinoma

    Renal cell carcinoma (RCC) accounts for about 2% of cancer diagnoses and deaths worldwide. Recent studies emphasized the critical involvement of...

    Ke Wu, Yaorong Li, ... Junhua Zheng in Cellular Oncology
    Article 25 October 2023
  11. Patients with metastatic renal cell carcinoma who receive immune-targeted therapy may derive survival benefit from nephrectomy

    Background

    Nephrectomy, whether in the era of cytokine therapy or targeted therapy, has an important role in the treatment of metastatic renal cell...

    Hanzhi Dong, Yuan Cao, ... Zhe Sun in BMC Cancer
    Article Open access 06 October 2023
  12. The mitochondrial fusion-associated protein MFN2 can be used as a novel prognostic molecule for clear cell renal cell carcinoma

    Background

    Mitofusin 2 (MFN2) plays an important role in many tumors, but how its role in renal clear cell carcinoma needs further research.

    ...
    Bin Zhang, Dali Han, ... Panfeng Shang in BMC Cancer
    Article Open access 16 October 2023
  13. PDZK1 confers sensitivity to sunitinib in clear cell renal cell carcinoma by suppressing the PDGFR-β pathway

    Background

    Sunitinib has emerged as the primary treatment for advanced or metastatic clear cell renal cell carcinoma (ccRCC) due to its significant...

    Haibo Wang, Lijie Zhang, ... Junqi He in British Journal of Cancer
    Article 31 May 2024
  14. Systematic analysis of RNASET2 gene as a potential prognostic and immunological biomarker in clear cell renal cell carcinoma

    Background

    RNASET2 has been identified as an oncogene with anti-angiogenic and immunomodulatory effects in a variety of cancers, but its function in...

    Yifu Liu, Zhicheng Zhang, ... Siyuan Wang in BMC Cancer
    Article Open access 07 September 2023
  15. CCDC25 suppresses clear cell renal cell carcinoma progression by LATS1/YAP-mediated regulation of the hippo pathway

    Background

    Clear cell renal cell carcinoma (ccRCC) is one of the most prevalent renal cancers, and the molecular mechanisms underlying its progression...

    Hongpei Tan, Jiahao Liu, ... Pengfei Rong in Cancer Cell International
    Article Open access 03 April 2024
  16. Multicenter randomized trial of deferred cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma receiving checkpoint inhibitors: the NORDIC-SUN-Trial

    Background

    Primary tumor removal by cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma patients has been investigated in the...

    Laura Iisager, Johanne Ahrenfeldt, ... Niels Fristrup in BMC Cancer
    Article Open access 24 February 2024
  17. Expression and Significance of BCCIP and Glutathione Peroxidase 4 in Clear Cell Renal Cell Carcinoma

    In this retrospective study involving 112 patients with clear cell renal cell carcinoma (ccRCC), we analyzed clinical significance and prognostic...

    Yao Liu, J. Liu, ... Yu Liu in Bulletin of Experimental Biology and Medicine
    Article 01 January 2024
  18. Hyperthermia inhibits cellular function and induces immunogenic cell death in renal cell carcinoma

    Background

    In recent years, hyperthermia has been widely applied as a novel strategy for cancer treatment due to its multiple antitumour effects. In...

    Yin Huaqi, Dong Bingqi, ... Yang Tiejun in BMC Cancer
    Article Open access 12 October 2023
  19. Multi-omic profiling of clear cell renal cell carcinoma identifies metabolic reprogramming associated with disease progression

    Clear cell renal cell carcinoma (ccRCC) is a complex disease with remarkable immune and metabolic heterogeneity. Here we perform genomic,...

    Junyi Hu, Shao-Gang Wang, ... Ke Chen in Nature Genetics
    Article Open access 15 February 2024
Did you find what you were looking for? Share feedback.